Skip to content
Menu

Diebold Nixdorf, Incorporated DBD

Full chart Compare
Set alert

Price alert · DBD

All alert types
51.86 USD +1.59 (+3.16%)

Regular-session close

51.86 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

49.92 Day range 52.07
50.27 52-week range 90.75
YTD
-23.61%
1 year
-13.58%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Gross Profit$1.00BCost of Revenue$2.80BNet Income$94.60MSelling, General & Admin$585.00MResearch & Development$83.80MInterest Expense$85.70MOther Expenses$130.20MIncome Tax$24.10MRevenue$3.81BService$2.17BProduct$1.64B

Latest period ending Dec 31, 2025 · select a line to chart its full history

DBD annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.81B3.75B3.46B3.91B
961.20M920.00M757.30M1.04B
242.00M182.10M-211.70M137.10M
94.60M-16.50M-581.40M-78.80M
2.54-0.44-7.36-1.01
DBD annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
387.30M311.30M319.10M—
3.85B3.54B3.06B—
2.75B2.61B4.44B—
938.50M927.30M2.73B—
1.10B929.80M-1.38B—
DBD annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
300.70M149.20M-387.90M123.30M
-97.60M-45.50M-23.80M-49.20M
-143.90M-366.50M349.80M-3.60M
-61.70M-40.40M-47.10M-49.60M
76.00M-281.00M-70.10M64.80M